CD40 and neoplasm: The combination of i.v. tumor plus anti-CD40 stimulated a large increase in HEL-specific serum IgG2a/c, with smaller increases in IgG1, IgG3, IgA and IgE and no change in IgG2b or IgM (Figure 7C and 7D).